TAPP and Open Repair for Recurrent Inguinal Hernia

September 18, 2024 updated by: Weiming Li, The Second Affiliated Hospital of Kunming Medical University

Clinical Study of Transabdominal Preperitoneal Approach Versus Open Tension-free Hernia Repair for the Treatment of Recurrent Inguinal Hernia

The objective of this study was to explore the clinical efficacy of transabdominal preperitoneal approach (TAPP) and open tension-free hernia repair in the treatment of recurrent inguinal hernia. This study aims to provide a basis for selecting the optimal treatment methods for recurrent hernias.

Study Overview

Status

Recruiting

Detailed Description

The patients were randomly allocated to the TAPP group and the open tension-free repair group. We recorded the general situation, operation time, and intraoperative complications; postoperative visual analogue pain scale (VAS) scores at 24 and 48 h; and the incidence of complications such as seroma, chronic pain, inguinal numbness, foreign body sensation, and recurrence at 1 week, 1 month, 3 months, 6 months and 1 year after surgery. These indicators were compared between the two groups of patients.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Yunnan
      • Kunming, Yunnan, China, 650000
        • Recruiting
        • Clinical study of recurrent inguinal hernia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age ≥ 18 years
  • the diagnosis of recurrent inguinal hernia made by ultrasound or computed tomography (CT) during the present visit
  • ability to tolerate general anesthesia and local anesthesia surgery
  • all patients and their families agreed to participate in this study and sign relevant informed consent.

Exclusion Criteria:

  • patch infection during the first surgery
  • multiple (≥ 2) relapses
  • inability to cooperate to complete follow-up after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transabdominal preperitoneal approach surgery group
The enrolled patients were treated with Transabdominal preperitoneal approach
The enrolled patients underwent either open tension-free hernia repair or Transabdominal preperitoneal approach
Other Names:
  • Open tension-free hernia repair
Other: Open tension-free hernia repair group
The enrolled patients were treated with open tension-free hernia repair
The enrolled patients underwent either open tension-free hernia repair or Transabdominal preperitoneal approach
Other Names:
  • Open tension-free hernia repair

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperation pain
Time Frame: 24 hours, 48 hours, three months after surgery
Postoperative pain was monitored using the VAS pain scoring system (0-10 points) and recorded at 24 and 48 h. Patients with groin pain for more than 3 months were recorded during follow-up.
24 hours, 48 hours, three months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numbness and foreign body sensation
Time Frame: The mean follow-up time was 10 months after surgery
The occurrence of groin numbness and foreign body sensation after operation was recorded
The mean follow-up time was 10 months after surgery
Operating time
Time Frame: During surgery
Record the patient's operating time
During surgery
Hemorrhage
Time Frame: During surgery
The amount of surgical bleeding was recorded
During surgery
Urinary retention
Time Frame: One week after surgery
Urinary retention was observed and recorded after operation
One week after surgery
Seroma
Time Frame: The mean follow-up time was 2 weeks after surgery
The occurrence of postoperative seroma was observed and recorded
The mean follow-up time was 2 weeks after surgery
Recurrence
Time Frame: The mean follow-up time was 1 year after surgery
The recurrence of patients after operation was observed and recorded
The mean follow-up time was 1 year after surgery
Fever
Time Frame: One week after surgery
The postoperative fever was observed and recorded
One week after surgery
Length of hospital stay
Time Frame: Within a week of surgery
The patient's length of stay was recorded
Within a week of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Weiming Li, doctor, The Second Affiliated Hospital of Kunming Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

October 28, 2025

Study Registration Dates

First Submitted

September 15, 2024

First Submitted That Met QC Criteria

September 18, 2024

First Posted (Estimated)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 18, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recurrent Inguinal Hernia

Clinical Trials on Transabdominal preperitoneal approach

Subscribe